Founded in 2018 by world-class industry experts and a group of top physicians in the nation, Acclaro Corporation is a US-based, fast-growing medical device company committed to innovating and developing game-changing solutions to address today’s most challenging unmet needs in the global medical aesthetic, ophthalmic and surgical markets.
Acclaro’s flagship product, UltraClear™, is the world’s first cold ablative, fractional fiber laser, a breakthrough nearly pain-free anti-aging solution and the most powerful all-in-one skin rejuvenation platform for all skin types, addressing the unmet needs of treating skin of color with significantly increased safety without muting the results.
Powered by the revolutionary MID IR Fiber Laser with the new wavelength of 2910nm and unrivalled precision energy control capabilities, UltraClear™ offers a full range of skin rejuvenation outcomes from true anti-aging lunchtime treatments to most advanced collagen remodeling.
With no consumables or per-pulse payments, avg. treatment times of 10 minutes and no topical numbing required for most procedures. UltraClear offers a rapid return on investment (ROI) for aesthetic providers. The unprecedented level of safety and ease of use make it prime for delegation to trained ancillary staff.